[1] 陆正民,冯晓鸿,杜合娟等.血清5′-NT、TBA与MAO检测对肝肿瘤的诊断价值.临床输血与检验,2017,19:605-608.
[2] 彭淑牖,黄从云,王许安,等.末梢门静脉栓塞联合肝肿瘤动脉化疗栓塞13例报告.中华外科杂志,2017,55:655-660.
[3] Fontes-Sousa M, Magalhes H, Machado B,et al. Pancreatic neuroendocrine tumor liver metastasisin a patient with previously diagnosed pancreatic adenocarcinoma: an unexpected diagnosis.癌症转移与治疗(英文版),2018:69-74.
[4] Ma L,Guan D,Ding QY,et al. Application of18F-FDG PET/CT in rare metastatic locations of esophageal carcinoma.国际转化医学杂志(英文版),2015:86-92.
[5] 曹耿飞,纪卫政,顾俊鹏,等.贝伐单抗联合TACE治疗TACE-抵抗性肝癌13例疗效观察.介入放射学杂志,2015,24:69-73.
[6] 王凇,郝艳红,杨薇,等.肝癌射频消融后肝脓肿的发生率及危险因素分析.中国介入影像与治疗学,2018,15:37-41.
[7] Lee GJ, Jo KW, Kim J,et al. Metastatic brain neuroendocrine tumor originating from the liver. J Korean Neurosurg Soc,2015,58:550-553.
[8] 李世兴,娄雪磊,吴焕卿.肝癌介入治疗后肝脓肿形成原因的临床分析.临床医药文献电子杂志,2015, 18:3667-3667,3670.
[9] 周颜,陈卫,王小林,等.转移性肝肿瘤TACE治疗后肝脓肿形成的临床特征及治疗分析.介入放射学杂志,2018,27:24-28. |
